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Abstract: Aims: Cardiac rehabilitation (CR) has proven to be effective and beneficial in middle-aged 
and older patients. However, solid data in large cohorts of elderly individuals are yet to be explored. 
This retrospective study investigated the general characteristics, outcomes, and the level of response 
of patients referred to CR over 13 consecutive years. Methods: We reviewed the medical records of 
patients admitted to Villa Pineta Rehabilitation Hospital for exercise-based CR from 2006 to 2018. 
The patients’ baseline characteristics and changes following CR in an upper-limb weightlifting test 
(ULW), 30-s sit-to-stand test (30STS), and the 6-min walking test (6MWT) with associated Borg-
related dyspnea (D) and fatigue (F) were collected. We also calculated the number of individuals 
that reached the minimal clinically relevant change (MCRC) following CR for each outcome. 
Results: One thousand five hundred and fifty-one patients (70.2 ± 9.7 years, 66% men) with complete 
datasets were included in the analysis. Coronary artery bypass graft and cardiac valve replacement 
surgery were the most frequent surgical procedures leading to CR referral (41.1% and 35.8%, 
respectively). The patients’ age (p = 0.03), number of total comorbidities (p < 0.0001), and post-
surgical complications (p = 0.02) significantly increased over time. In contrast, the average absolute 
changes in ULW, 30STS, and 6MWT with associated D and F, and the proportion of patients that 
reached their respective MCRC, remained constant over the same period. Conclusion: The patients 
admitted to exercise-based CR were older and had more comorbidities and complications over time. 
The outcomes, however, were not influenced in terms of the absolute change or clinically 
meaningful response. 
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1. Introduction 
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality in 
Western countries, with a high socioeconomic burden [1]. 
Cardiac rehabilitation (CR) is a multidimensional secondary prevention program 
that has become a standardized component of CVD management, since CR has proven to 
be beneficial for mobility, muscle strength and mass, physical performance, social 
participation, and the mood of patients with CVDs [1,2].  
Although CR originated as an exercise training program addressing middle-aged 
individuals affected by coronary heart disease, it has evolved into a comprehensive 
program promoting an active and healthier lifestyle for a broad range of CVDs (coronary 
heart disease, heart failure, valvular heart disease, etc.) through education, diet, and risk 
factor reduction [3]. Thus, CR is currently recommended for individuals affected by 
different CVDs, with increasing evidence of its beneficial effects in older populations [2].  
The advances in treatment have led to the chronification of CVDs, and the rationale 
for recommending CR to the expanding senior population is sound, as most of the risk 
factors for CVDs are age-related. Nonetheless, very few older individuals participate in 
CR [4], and compelling evidence has pointed out a lack of healthcare professional referral 
of all patients who could benefit from it [5]. CR could lessen the impact of CVDs on the 
physical performance and quality of life in the elderly, who can especially be affected [6]. 
However, CR in the elderly must be adapted to several geriatric variables, such as frailty, 
cardiovascular and non-cardiovascular multimorbidity, polypharmacy, physical 
deconditioning, and declining cognition, among others. Thus, CVD management in this 
population always requires a fair balance between costs and benefits; the focus should be 
on the patient’s needs, avoiding burdensome treatments in the face of minimal benefits. 
Hence, collecting further evidence on the effectiveness of CR on clinically relevant 
outcomes in eligible patients is recommended, particularly in the elderly population, in 
order to increase the referral and participation rates [7]. 
The aim of this retrospective study was to investigate the demographic and the 
clinical characteristics and outcomes of patients referred to CR over 13 consecutive years. 
If changes occurred over time, we also examined the level of response to CR (i.e., the 
achievement of clinically relevant gains in the outcomes collected) in the same period. 
2. Methods 
2.1. Study Design and Data Sources 
This retrospective study investigated a cohort of patients admitted for inpatient CR 
after cardiac surgery over a 13-year period (2006–2018).  
We retrieved data from the medical records database of the Villa Pineta 
Rehabilitation Hospital-KOS Group (Gaiato di Pavullo, Modena, Italy). The database 
contained information on inpatient care, including demographic information, diagnoses, 
surgical procedures, CR program, and the assessments performed.  
Consent to collect personal data and to use it in observational studies was obtained 
from all patients on admission. Moreover, as per the protocol approved by the local ethics 
committee (AOU: 0011677/19, date 18 April 2019), specific consent to use the data for the 
purposes of this study was obtained from patients who were still in follow-up at the time 
of data collection.  
2.2. Cardiac Rehabilitation Program 
On admission, all patients underwent a thorough assessment of their clinical, 
physical, and psychosocial characteristics by the multidisciplinary team, which included 
cardiologists, pneumologists, physiotherapists, nurses, dieticians, and psychologists. 
After a team discussion, a personalized exercise-based rehabilitation program targeting 
patient-specific objectives was developed by the physiotherapists and cardiologists. The 
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prerequisite for this individualized program was to target the patient’s maximal tolerated 
activity to achieve the best results (outcome measures). 
The CR program included exercise training, physical activity and nutritional 
counselling, weight control, psychosocial status management, medication rationalization, 
and strategies to keep the CVD risk factors under control, as recommended [1].  
The muscle training program consisted of intensive daily 2-h supervised exercise 
(generally once in the morning and once in the afternoon). The program included active 
mobilization of the shoulder girdle; upper and lower limb muscle stretching; and aerobic 
exercises (e.g., stationary bicycle, treadmill, etc.) at increasing loads. 
CR also included the treatment of surgical wounds and chest physiotherapy to assist 
and promote the clearance of excessive bronchial secretions. 
2.3. Data Collection and Outcome Assessment  
Data regarding age; sex; self-reported comorbidities (as assessed by the Charlson 
Comorbidity Index); type of surgery; duration of inpatient stay; the number of CR sessions 
performed; and the number of complications post-surgery (i.e., infections, bleeding, etc.) 
were collected from the medical records database. The assessments of the CR outcomes 
(i.e., the measures of functional muscle strength and walking exercise capacity) were also 
compared at the baseline (T0) and after CR (T1) by means of the following pre-defined 
measures: upper-limb weightlifting test (ULW), a 30-s sit-to-stand test (30STS), a 6-min 
walking test (6MWT), and the associated level of dyspnea (D) and fatigue (F) measured 
using the Borg scale [8]. The 30STS and the 6MWT were conducted according to the 
standardized recommendations [9,10]. The ULW test consisted of recording the number 
of full flexions and extensions of the elbows that male and female patients could perform 
while lifting weights of 2 kg and 1 kg, respectively. The patients were seated on the same 
chair used for the 30STS, with their upper limbs adducted, fully extended, and extra-
rotated. 
The minimal clinically relevant change (MCRC) following CR was also individually 
calculated for each outcome as follows: ≥1 repetition for ULW [11,12], >2 repetitions for 
the 30STS [13,14], +30 m for 6MWD [15], and −1 point for BORG D-F [16,17].  
2.4. Data Analysis  
The statistical packages SPSS version 25.0 (IBM Corp., New York, NY, USA) [18], 
GraphPad Prism 8.0 (GraphPad Software, Inc., La Jolla, CA, USA) [19], and Jamovi 1.2.27 
(Jamovi Project, Sydney, NSW, Australia) [20] were used for the statistical analyses. 
Descriptive statistics reporting the numbers and percentages for the dichotomous 
variables and means ( standard deviations (SD)) and medians (interquartile ranges 
(IQR)) for the continuous variables were applied to describe the data year by year. The 
average values (SD) or medians (IQR) for the functional outcomes of the CR were 
described at the baseline (T0) and after the completion of CR (T1), as well as their changes. 
Before the analysis, the data were checked with a Bartlett’s test for equal distribution of 
the variances. A linear mixed effects model was then built to assess the changes in the 
average values of the baseline characteristics across the years, considering both patients 
and years as random effects to avoid an estimation bias. The absolute numbers and 
percentages of patients who reached the MCRC after the CR for each outcome were 
reported. Three categories of patients with different response profiles were generated as 
follows and then considered for the analysis: (a) high responders (five outcomes reaching 
the MCRC at T1), (b) moderate responders (three to four outcomes reaching the MCRC), 
and (c) low responders (up to two outcomes reaching the MCRC). A chi-square test was 
performed to test the changes in the proportions within the time (years)-dependent 
groups. A two-sided test of less than 0.05 was considered statistically significant. 
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3. Results 
From January 2006 to December 2018, two thousand and five individuals underwent 
CR at our hospital, of whom 364 were not deemed eligible, as they had not undergone 
recent surgery. We therefore reviewed 1641 medical records; of these, 90 were excluded 
for the reasons illustrated in Figure 1. 
 
Figure 1. A flowchart of the patients’ records reviewed for eligibility. 
A total number of 1551 patients with complete pre-to-post data were included in the 
study, and their main characteristics by year are shown in Table 1. Overall, the average 
patient age was 70.2 years (±9.7), and 66% were men (n = 1018). Coronary artery bypass 
graft (CABG) and cardiac valve replacement surgery (CVS) were the most represented 
surgical procedures (41.1% and 35.8%, respectively), followed by plastic surgery of the 
mitral valve (10.3%); the remaining patients reported mixed conditions. The median index 
score of the chronic comorbidities was 2 (IQR 1;4), with hypertension (58.6%) and cardiac 
arrhythmias (43.2%) being the most frequent. The complications post-surgery were 
relatively few (see the details in Table 1). During their hospital stay (16 ± 3.6 days), the 























Legend: CR = Cardiac Rehabilitation 
Patients who underwent CR between 2006 and 2018 (n = 2005) 
Excluded because they had not undergone 
recent cardiac surgery (n = 364) 
Medical records reviewed of patients admitted for post-operative CR (n = 1641) 
Excluded (n = 90) 
incomplete data (n = 26) 
voluntary interruption of CR (n = 18)  
worsening of clinical conditions (n = 40) 
deceased (n = 3) 
poor adherence to CR (n = 3) 
Included in analyses (n = 1551) 
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Table 1. The characteristics of the study cohort by year. 
Year Pt. F M Age Main Diagnosis Comorbid. Complic. CR Sessions 
Hospital 
Stay 





Mean ± SD Mean ± SD 
2006 65 22 (34) 43 (66) 69.7 ± 10.1 CABG (54%) 1 (1;3) 0 (0;1) 13.8 ± 2.9 16.5 ± 3.3 
2007 94 24 (26) 70 (75) 68.0 ± 10.1 CABG (44%) 2 (1;3) 0 (0;1) 14.1 ± 3.3 17.0 ± 4.0 
2008 79 24 (30) 55 (70) 68.6 ± 9.3 CABG (41%) 1 (0;3) 0 (0;1) 14.8 ± 3.2 18.1 ± 4.6 
2009 112 38 (34) 74 (66) 69.5 ± 10.1 CABG (47%) 2 (1;3) 0 (0;1) 13.4 ± 3.5 16.5 ± 4.4 
2010 83 30 (36) 53 (64) 70.2 ± 9.7 CABG (46%) 2 (1;3) 1 (0;1) 13.6 ± 3.6 16.5 ± 4.8 
2011 121 38 (31) 83 (69) 70.0 ± 10.5 CVS (38%) 2 (1;4) 0 (0;1) 13.3 ± 2.8 16.3 ± 3.9 
2012 168 67 (40) 101 (60) 70.0 ± 9.5 CVS (41%) 2 (1;4) 0 (0;1) 12.8 ± 2.7 15.9 ± 3.7 
2013 193 60 (31) 133 (69) 70.9 ± 10.2 CVS (40%) 2 (1;3) 0 (0;1) 12.7 ± 2.1 15.4 ± 2.9 
2014 87 40 (46) 47 (54) 69.8 ± 11.6 CVS (45%) 3 (2;4) 1 (0;1) 12.9 ± 2.4 15.9 ± 2.9 
2015 100 33 (33) 67 (67) 69.6 ± 9.5 CABG (41%) 2 (1;3) 0 (0;1) 13.2 ± 3.6 16.1 ± 5.3 
2016 104 48 (46) 56 (54) 70.9 ± 9.3 CVS (47%) 2 (1;3) 0 (0;1) 12.7 ± 1.6 15.3 ± 1.9 
2017 197 65 (33) 132 (67) 71.4 ± 8.4 CABG (44%) 3 (2;4) 0 (0;1) 12.9 ± 1.6 15.5 ± 2.0 
2018 148 44 (30) 104 (70) 71.1 ± 9.6 CABG (43%) 3 (2;4) 1 (0;1) 12.8 ± 1.8 15.4 ± 2.7 
Total 1551 533 (34) 1018 (66) 70.2 ± 9.7 CABG (41%) 2 (1;4) 0 (0;1) 13.2 ± 2.7 16.0 ± 3.6 
Note: Pt., Patients; F, Female; M, Male; Comorbid., Comorbidities; Complic., Complications; CR, Cardiac Rehabilitation; 
n, number; SD, Standard Deviation; Freq., Frequency; IQR, Interquartile Range; CABG, Coronary Artery Bypass Graft; 
CVS, Cardiac Valve replacement Surgery. 
Over the 13-year timespan, the patient age (p = 0.03), number of total comorbidities 
(p < 0.0001), and clinical complications post-surgery (p = 0.02) significantly increased, 
whereas the length of hospital stay and the number of CR sessions attended decreased (p 
< 0.0001 for both). 
Table 2 reports the CR outcomes (see the Methods section) both at T0 and T1 and 
displays the pre-to-post changes following the CR, which were all statistically significant 
(p < 0.001) and which indicated a good response to the CR. The average changes were not 
significantly different over the years for all the predetermined outcomes. The number of 
individuals who reached the MCRC for each CR outcome during the period examined is 
reported in Table 3; only Borg F showed a significant reduction in the proportion of 
patients reaching the MCRC (p < 0.001) over the years. 
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Table 2. Outcome changes over the CR course and during the considered timespan. 
Year ULW 30STS 6MWD Borg D Borg F 
 T0 T1 ∆ T0 T1 ∆ T0 T1 ∆ T0 T1 ∆ T0 T1 ∆ 
 Mean ± SD Mean ± SD Mean ± SD Median IQR (25;75) Median IQR (25;75) 
2006 11.9 ± 6.9 18.5 ± 6.7 6.5 ± 4.7 6.8 ± 5.9 10.3 ± 7.0 3.5 ± 3.9 239 ± 161 354 ± 142 115 ± 93 6 (5;7) 2 (2;4) −3 (−4;−2) 6 (5;7) 3 (2;4) −3 (−4;−2) 
2007 13.4 ± 6.2 19.9 ± 6.5 6.4 ± 5.1 7.5 ± 5.2 10.9 ± 6.2 3.2 ± 3.0 242 ± 132 336 ± 131 94 ± 74 5 (4;7) 2 (1;4) −3 (−4;−2) 5 (4;7) 2 (1;4) −3 (−4;−2) 
2008 14.3 ± 7.0 19.8 ± 6.9 5.0 ± 4.9 7.1 ± 6.1 10.8 ± 7.0 3.5 ± 3.0 235 ± 139 342 ± 131 107 ± 71 6 (5;7) 2 (1;4) −3 (−4;−2) 6 (5;7) 2 (1;3) −3 (−5;−2) 
2009 14.4 ± 6.7 20.5 ± 6.4 5.7 ± 5.1 8.0 ± 5.4 12.2 ± 6.2 3.4 ± 3.4 231 ± 131 342 ± 127 110 ± 72 6 (4;7) 2 (2;3) −3 (−4;−2) 6 (4;8) 3 (2;4) −3 (−4;−2) 
2010 19.4 ± 6.6 25.2 ± 8.0 4.7 ± 6.9 9.5 ± 4.6 13.9 ± 5.8 3.2 ± 3.3 243 ± 131 356 ± 118 114 ± 63 5 (3;6) 2 (1;3) −2 (−4;−1) 5 (3;6) 2 (1;3) −3 (−4;−2) 
2011 19.7 ± 8.2 25.3 ± 8.1 4.8 ± 6.2 9.4 ± 6.1 13.3 ± 5.8 2.9 ± 3.3 263 ± 137 359 ± 133 96 ± 62 4 (3;6) 2 (2;3) −2 (−3;−1) 4 (3;6) 2 (1;3) −2 (−3;−1) 
2012 18.7 ± 6.4 25.0 ± 6.6 5.4 ± 5.0 8.7 ± 4.5 13.1 ± 5.2 3.3 ± 3.1 237 ± 120 346 ± 119 109 ± 67 5 (3;7) 2 (1;3) −2 (−4;−1) 4 (3;6) 2 (1;3) −2 (−4;−1) 
2013 19.6 ± 6.1 25.2 ± 5.7 4.9 ± 4.3 9.6 ± 4.5 13.4 ± 5.1 3.1 ± 2.9 259 ± 118 357 ± 126 99 ± 63 4 (3;5) 2 (1;2) −2 (−3;−1) 4 (2;6) 2 (1;3) −2 (−3;−1) 
2014 20.1 ± 7.7 26.9 ± 10.8 6.2 ± 8.5 8.8 ± 4.9 13.4 ± 5.0 3.5 ± 3.5 241 ± 122 356 ± 117 115 ± 64 5 (3;8) 2 (1;3) −3 (−4;−2) 4 (3;7) 2 (1;4) −2 (−4;−1) 
2015 17.7 ± 6.4 24.9 ± 7.6 6.7 ± 5.7 9.5 ± 4.8 13.6 ± 5.2 3.4 ± 3.2 271 ± 118 389 ± 124 118 ± 77 4 (3;7) 2 (1;3) −2 (−4;−1) 4 (2;7) 2 (0;3) −2 (−4;−1) 
2016 18.3 ± 6.8 24.9 ± 7.2 6.0 ± 6.2 8.6 ± 5.3 12.9 ± 6.2 3.6 ± 4.3 270 ± 119 379 ± 122 110 ± 70 4 (3;5) 2 (1;3) −2 (−3;−1) 4 (3;5) 2 (1;2) −2 (−3;−1) 
2017 19.3 ± 6.7 25.4 ± 7.1 5.6 ± 5.2 8.3 ± 5.2 12.5 ± 5.0 3.6 ± 3.1 271 ± 108 378 ± 110 107 ± 61 5 (3;6) 2 (1;3) −3 (−4;−1) 4 (2;6) 2 (1;3) −2 (−4; 0) 
2018 17.9 ± 6.2 23.4 ± 6.2 5.5 ± 5.0 8.4 ± 4.5 12.0 ± 4.2 3.5 ± 2.4 267 ± 105 376 ± 122 109 ± 61 4 (3;6) 2 (1;3) −3 (−4;−1) 4 (2;6) 2 (1;3) −2 (−4;−1) 
Total 17.7 ± 7.1 23.8 ± 7.5 5.6 ± 4.9 8.6 ± 5.2 12.6 ± 5.6 3.4 ± 4.2 254 ± 124 361 ± 124  107 ± 68 5 (3;7) 2 (1;3) −3 (−4;−1) 5 (3;7) 2 (1;3) −2 (−4;−1) 
Note: ULT, Upper-Limb Weightlifting; 30STS, 30-sec Sit-To-Stand test; 6MWD, 6-Min Walked Distance; D, Dyspnea; F, Fatigue; T0, baseline assessment; T1, follow-up; ∆, changes after 
cardiac rehabilitation; SD, Standard Deviation; IQR, Interquartile Range. 
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Table 3. Patients reaching the MCRC in each outcome following the CR and during the considered timespan. 
Year ∆ULW ∆30STS ∆6MWD ∆Borg D ∆Borg F 
 n % n % n % n % n % 
2006 42 64.6 37 56.9 58 89.2 58 89.2 56 86.2 
2007 54 57.4 47 50.0 80 85.1 85 90.4 85 90.4 
2008 42 53.2 45 57.0 68 86.1 70 88.6 74 93.7 
2009 60 53.6 65 58.0 103 92.0 100 89.3 101 90.2 
2010 36 43.4 42 50.6 80 96.4 72 86.7 75 90.4 
2011 52 43.0 55 45.5 106 87.6 94 77.7 101 83.5 
2012 88 52.4 92 54.8 152 90.5 145 86.3 143 85.1 
2013 90 46.6 112 58.0 171 88.6 159 82.4 160 82.9 
2014 45 51.7 48 55.2 80 92.0 75 86.2 65 74.7 
2015 58 58.0 56 56.0 94 94.0 87 87.0 77 77.0 
2016 55 52.9 62 59.6 95 91.3 83 79.8 81 77.9 
2017 104 52.8 121 61.4 186 94.4 162 82.2 135 68.5 
2018 73 49.3 84 56.8 140 94.6 123 83.1 115 77.7 
Total 799 51.5 866 55.8 1413 91.1 1313 84.7 1268 81.8 
Note: ULT, Upper-Limb Weightlifting; 30STS, 30-sec Sit-To-Stand test; 6MWD, 6-Min Walked Distance; D, Dyspnea; F, 
Fatigue. 
According to the categories of the response to CR (see the Methods section), the 
majority of the cases were high (24.4%; n = 379) or moderate (71.3%, n =1106) responders, 
whereas only a very few (4.3%, n = 66) were poor responders. Figure 2 shows the 
distribution of the categories of response across the timespan, revealing an increase in 
moderate responders at the expense of the high-response category within the same 
timeframe (p = 0.02) 
 
Figure 2. Clusters of responses across 13 years. 




This retrospective study reports unique information on the outcomes following a 
standard exercise-based CR in a very large population of patients over a considerable 
period of time. We observed that patients’ age and clinical characteristics significantly 
changed over the 13 years examined. Notwithstanding this, the predetermined outcomes 
were not influenced in terms of the absolute change and in terms of the number of patients 
reaching the respective MCRC. Of note, the categories of response showed a progressive 
percentage increase in the “moderate responders”, whilst the proportion of “low 
responders” remained stable. 
Overall, we believe that the main finding of this study is that it confirmed a good 
quantitative response to CR [2], irrespective of the clinical characteristics of the patients 
admitted. Cardiac patient referrals to rehabilitation may differ and/or change over time 
for several reasons. In our center, located in Northeastern Italy, referrals are for post-
surgical patients, who represent the core business and interest of the local (regional) 
stakeholders. Across the 13 years studied, older patients with more comorbidities were 
referred for surgery, since medical care has improved [21] and minimally invasive 
techniques are more frequently used in younger patients at a higher risk [22]. Nonetheless, 
comorbidities in chronic and disabled individuals do not preclude access to rehabilitation 
and its benefits [23]. 
Very recently, a systematic review including six trials and 364 participants confirmed 
that exercise-based CR is likely to improve specific outcomes in patients referred after 
heart valve surgery [24], although the effects in terms of mortality, hospitalization, and 
health-related quality of life are still uncertain and/or partly unexamined. Our study 
therefore further supports the indication for CR after cardiac surgery (>70% of 
patients/year) irrespective of age and comorbidities, based on both the absolute change in 
CR outcomes (see Table 2) and the proportion of patients reaching the clinically 
meaningful criteria for improvement (see Table 3). Of note, the MCRCs did not 
substantially change over time in all the CR outcomes, except for Borg-F, as assessed 
during the exercise tolerance test. It is difficult to explain this result; it may be associated 
with the changes in the patients’ characteristics observed over time, with a progressive 
increase in the referral to CR of older patients with more comorbidities less responsive to 
perceived fatigue [25].  
Thus, to date, CR after surgery still remains a valid therapeutic, nonpharmacological 
opportunity for eligible candidates. Further, it appears much better than preoperative 
physiotherapy, which, according to the literature, still shows conflicting results [26,27].  
It is noteworthy that the quantitative gains showed by the cohort examined were 
maintained by reducing the number of days spent in hospital and (slightly) the mean 
number of CR sessions attended per patient, thus making a better cost-effective 
intervention possible in more recent years. The considerable timespan observed might 
have indeed improved the staff’s ability to use resources better and/or may demonstrate 
an optimization of the learning curve of healthcare professionals working with people 
with multiple comorbidities [28]; however, a formal cost-effective analysis was not 
possible with this retrospective design, and it was beyond the scope of the study. 
Finally, we were also able to demonstrate that the qualitative response (i.e., the 
response categories as described in the Methods section) did not substantially change over 
time, although the proportion of “moderate responders” increased compared to the “high 
responders” (see Figure 2). It is questionable whether this variation had any significant 
implication on the effectiveness of the CR program (which remained constant over time). 
Nonetheless, over the years, the number of poor responders remained stable and very low 
(less than 5%) across the treated population.  
Notwithstanding the positive findings observed, this retrospective study has obvious 
limitations. Firstly, this retrospective study provided information that needs to be 
confirmed prospectively. Secondly, due to the quite long time period examined, the 
patients’ post-surgery recovery pathway could have been affected both by the evolution 
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in surgical procedures and by an increase in the staff’s experience. Thirdly, as the study 
was conducted in a single center, with a unique rehabilitation approach, our results cannot 
be generalized or considered as valid for any candidate to CR. Nevertheless, to the best of 
our knowledge, this study is the first to show a composite treatment response evaluation 
after CR. Previous reports in the rehabilitation of chronic respiratory patients have shown 
that the key performance measures to evaluate the effectiveness of programs had to be 
selected within multiple domains, including those related to what a patient perceives in 
his/her daily life [29]. Despite the fact that, in this study, we did not collect a wide range 
of measures to assess the patients’ outcomes, we do believe that both the selected 
performance measures [1,2] and the composite response to these performances might 
have reflected the benefits obtained in those patients’ everyday lives. 
5. Conclusions 
In conclusion, this retrospective analysis of a very large population confirms the 
benefits of CR even in older patients with comorbidities undergoing cardiac surgery and 
opens a window into the area of composite responses in this specific field of rehabilitation.  
Author Contribution: Study conception and design: E.C., M.C., M.V., N.T., F.F., A.B., S.C., R.T., and 
S.B.; data collection: N.T., A.B., F.F., and M.C.; analysis and interpretation of the results: R.T., S.C., 
M.V., S.B., and E.C.; and draft manuscript preparation: S.C., R.T., S.B., and E.C. All authors have 
read and reviewed the results and approved the final version of the manuscript. 
Funding: This research received no specific grant from any funding agency in the public, 
commercial, or nonprofit sectors. 
Institutional Review Board Statement: The study was conducted according to the guidelines of the 
Declaration of Helsinki and approved by the Ethics Committee of the University Hospital of 
Modena (Italy) (AOU: 0011677/19, date 18 April 2019). 
Informed Consent Statement: Informed consent was obtained from all subjects involved in the 
study. 
Data Availability Statement: The data underlying this article cannot be shared publicly due to the 
privacy of the individuals that contributed to the study with their data. The data can be shared on 
reasonable request to the corresponding author. 
Acknowledgments: The authors thank Jacqueline M. Costa for the English language editing. 
Conflicts of Interest: The authors declare that there are no conflicts of interest. 
References 
1. Piepoli, M.F.; Corrà, U.; Adamopoulos, S.; Benzer, W.; Bjarnason-Wehrens, B.; Cupples, M.; Dendale, P.; Doherty, P.; Gaita, D.; 
Höfer, S.; et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, 
standards and outcome measures for referral and delivery: A policy statement from the cardiac rehabilitation section of the 
European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of 
the European Society of Cardiology. Eur. J. Prev. Cardiol. 2014, 21, 664–681, doi:10.1177/2047487312449597. 
2. Piepoli, M.F.; Hoes, A.W.; Agewall, S.; Albus, C.; Brotons, C.; Catapano, A.L.; Cooney, M.-T.; Corra, U.; Cosyns, B.; Deaton, C.; 
et al. Linee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica. Sesta Task Force congiunta 
della Società Europea di Cardiologia e di altre Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica 
(costituita da rappresentanti di 10 società e da esperti invitati). Redatte con il contributo straordinario dell’Associazione Europea 
per la Prevenzione e Riabilitazione Cardiovascolare (EACPR) [2016 European guidelines on cardiovascular disease prevention 
in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular 
Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with 
the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]. G. Ital. Cardiol. 2017, 18, 
547–612, doi:10.1714/2729.27821. 
3. Schopfer, D.; Forman, D.E. Cardiac Rehabilitation in Older Adults. Can. J. Cardiol. 2016, 32, 1088–1096, 
doi:10.1016/j.cjca.2016.03.003. 
4. Suaya, J.A.; Shepard, D.S.; Normand, S.-L.T.; Ades, P.A.; Prottas, J.; Stason, W.B. Use of Cardiac Rehabilitation by Medicare 
Beneficiaries After Myocardial Infarction or Coronary Bypass Surgery. Circulation 2007, 116, 1653–1662, 
doi:10.1161/CIRCULATIONAHA.107.701466. 
Int. J. Environ. Res. Public Health 2021, 18, 8871 10 of 10 
 
 
5. Khadanga, S.; Savage, P.D.; Gaalema, D.E.; Ades, P.A. Predictors of Cardiac Rehabilitation Participation: OPPORTUNITIES TO 
INCREASE ENROLLMENT. J. Cardiopulm. Rehabil. Prev. 2021, doi:10.1097/hcr.0000000000000573. 
6. Kirk, H.; Kersten, P.; Crawford, P.; Keens, A.; Ashburn, A.; Conway, J. The cardiac model of rehabilitation for reducing 
cardiovascular risk factors post transient ischaemic attack and stroke: A randomized controlled trial. Clin. Rehabil. 2014, 28, 339–
349, doi:10.1177/0269215513502211. 
7. Thomas, R.J.; Balady, G.; Banka, G.; Beckie, T.M.; Chiu, J.; Gokak, S.; Ho, P.M.; Keteyian, S.J.; King, M.; Lui, K.; et al. 2018 
ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of 
Cardiology/American Heart Association Task Force on Performance Measures. J. Am. Coll. Cardiol. 2018, 71, 1814–1837, 
doi:10.1016/j.jacc.2018.01.004. 
8. Borg, G.A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982, 14, 377–381. 
9. Jones, C.J.; Rikli, R.E.; Beam, W.C. A 30-s Chair-Stand Test as a Measure of Lower Body Strength in Community-Residing Older 
Adults. Res. Q. Exerc. Sport 1999, 70, 113–119, doi:10.1080/02701367.1999.10608028. 
10. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the six-
minute walk test. Am. J. Respir. Crit. Care Med. 2002, 166, 111–117, doi:10.1164/ajrccm.166.1.at1102. Erratum in Am. J. Respir. Crit. 
Care Med. 2016, 193, 1185. 
11. Samsa, G.; Edelman, D.; Rothman, M.L.; Williams, G.R.; Lipscomb, J.; Matchar, D. Determining clinically important differences 
in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 
PharmacoEconomics 1999, 15, 141–155, doi:10.2165/00019053-199915020-00003. 
12. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Lawrence Erlbaum Associates: Hillsdale, NJ, USA, 1988. 
13. Ozalevli, S.; Ozden, A.; Itil, O.; Akkoclu, A. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic 
obstructive pulmonary disease. Respir. Med. 2007, 101, 286–293, doi:10.1016/j.rmed.2006.05.007. 
14. Wright, A.A.; Cook, C.E.; Baxter, D.; Dockerty, J.D.; Abbott, J.H. A Comparison of 3 Methodological Approaches to Defining 
Major Clinically Important Improvement of 4 Performance Measures in Patients With Hip Osteoarthritis. J. Orthop. Sports Phys. 
Ther. 2011, 41, 319–327, doi:10.2519/jospt.2011.3515. 
15. Singh, S.J.; Puhan, M.; Andrianopoulos, V.; Hernandes, N.A.; Mitchell, K.E.; Hill, C.J.; Lee, A.L.; Camillo, C.A.; Troosters, T.; 
Spruit, M.A.; et al. An official systematic review of the European Respiratory Society/American Thoracic Society: Measurement 
properties of field walking tests in chronic respiratory disease. Eur. Respir. J. 2014, 44, 1447–1478, doi:10.1183/09031936.00150414. 
16. Ries, A.L. Minimally Clinically Important Difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual 
Analog Scale. COPD J. Chronic Obstr. Pulm. Dis. 2005, 2, 105–110, doi:10.1081/copd-200050655. 
17. Khair, R.M.; Nwaneri, C.; Damico, R.L.; Kolb, T.; Hassoun, P.M.; Mathai, S.C. The Minimal Important Difference in Borg 
Dyspnea Score in Pulmonary Arterial Hypertension. Ann. Am. Thorac. Soc. 2016, 13, 842–849, doi:10.1513/AnnalsATS.201512-
824OC. 
18. IBM Corp. IBM SPSS Statistics for Windows, Version 25.0; IBM Corp: Armonk, NY, USA, 2017. 
19. GraphPad Prism Version 8.0.0 for Windows, GraphPad Software. Available online: https://www.graphpad.com (accessed on 
14 June 2021). 
20. The Jamovi Project (2020). Jamovi. (Version 1.2) [Computer Software]. Available online: https://www.jamovi.org (accessed on 
14 June 2021). 
21. Sartini, C.; Lomivorotov, V.; Pisano, A.; Riha, H.; Redaelli, M.B.; Lopez-Delgado, J.C.; Pieri, M.; Hajjar, L.; Fominskiy, E.; 
Likhvantsev, V.; et al. A Systematic Review and International Web-Based Survey of Randomized Controlled Trials in the 
Perioperative and Critical Care Setting: Interventions Increasing Mortality. J. Cardiothorac. Vasc. Anesth. 2019, 33, 2685–2694, 
doi:10.1053/j.jvca.2019.03.022. 
22. Wang, C.; von Segesser, L.K.; Berdajs, D.; Ferrari, E. Endovascular treatment of the dissected proximal aortic arch: A systematic 
review. Interact. Cardiovasc. Thorac. Surg. 2021, ivab161, doi:10.1093/icvts/ivab161. 
23. Tonelli, R.; Crisafulli, E.; Costi, S.; Clini, E. The multimorbidity patient. In Pulmonary Rehabilitation; Donner, C., Ambrosino, N., 
Goldstein, R., Eds.; Taylor & Francis Group: London, UK, 2020; pp. 349–357. 
24. Abraham, L.N.; Sibilitz, K.L.; Berg, S.K.; Tang, L.H.; Risom, S.S.; Lindschou, J.; Taylor, R.S.; Borregaard, B.; Zwisler, A.-D. 
Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst. Rev. 2021, 5, CD010876, 
doi:10.1002/14651858.cd010876.pub3. 
25. Baker, N.; Lawn, S.; Gordon, S.J.; George, S. Older Adults’ Experiences of Goals in Health: A Systematic Review and 
Metasynthesis. J. Appl. Gerontol. 2021, 40, 818–827, doi:10.1177/0733464820918134. 
26. Hulzebos, E.H.; Smit, Y.; Helders, P.P.; van Meeteren, N.L. Preoperative physical therapy for elective cardiac surgery patients. 
Cochrane Database Syst. Rev. 2012, 11, CD010118, doi:10.1002/14651858.CD010118.pub2. 
27. Snowdon, D.; Haines, T.; Skinner, E.H. Preoperative intervention reduces postoperative pulmonary complications but not 
length of stay in cardiac surgical patients: A systematic review. J. Physiother. 2014, 60, 66–77, doi:10.1016/j.jphys.2014.04.002. 
28. Mölken, M.R.-V.; Leijten, F.; Hoedemakers, M.; Tsiachristas, A.; Verbeek, N.; Karimi, M.; Bal, R.; De Bont, A.; Islam, K.; 
Askildsen, J.E.; et al. Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-
Criteria Decision Analysis (MCDA). BMC Health Serv. Res. 2018, 18, 576, doi:10.1186/s12913-018-3367-4. 
29. Ambrosino, N.; Clini, E. Response to pulmonary rehabilitation: Toward personalised programmes? Eur. Respir. J. 2015, 46, 1538–
1540, doi:10.1183/13993003.01125-2015. 
